INTRODUCTION
The ski oncogene (v-ski), which was originally isolated from Sloan-Kettering avian retroviruses, has been shown to cause anchorage-independent growth and morphological transformation and to induce myogenesis in itro [1] [2] [3] [4] . c-ski, the cellular counterpart of v-ski, is also capable of inducing not only expression of MyoD and myogenin in otherwise non-myogenic quail embryo cells but also morphological transformation of chicken embryo cells when overexpressed [5] . Consistent with these findings, members of the ski-gene family are expected to be present at a check point in the G ! phase to direct cells toward differentiation or into the cell cycle [6] according to their competence. It has been reported that c-ski transcripts are expressed in dermomyotome from early on in myogenic commitment to terminal differentiation of skeletal muscles [7] . In transgenic mice, c-ski transgene expression was found to be muscle-specific and caused muscular hypertrophy with increases in type-IIb fast-muscle mass [8] . In situ analysis in transgenic mice also revealed that c-ski transcript was less abundant at birth and then increased temporarily in fast-muscle fibres between 5 and 12 days post partum resulting in a hypertrophic effect on the formation of first muscle IIb fibres [9] . In addition, atrophy of fast-muscle fibres by denervation caused c-ski mRNA to decrease significantly [9] . Thus c-ski gene product may have a role in the process from commitment to differentiation\maturity leading to formation of the specialized muscle phenotype.
Analysis of the myogenic process is required to elucidate the Abbreviations used : CAT, chloramphenicol acetyltransferase ; MCK, muscle creatine kinase ; MLC, myosin light chain ; SV40, simian virus 40. 1 To whom correspondence should be addressed.
conditions. Thus the ski-dependent potentiation of myogenin gene transcriptional activity appears to be specific for myogenesis. The C-terminal region (amino acids 595-663) of the c-Ski protein was essential for the potentiating activity in myotubes. Other members of the ski-gene family, snoN and snoA, were ineffective in transactivation, possibly because of the defect in the corresponding C-terminal region. c-Ski protein underwent a mobility shift on SDS\PAGE after in itro myogenesis which may explain the conversion of the activity from suppressive in myoblasts to potentiating in myotubes. Deletion analysis of the upstream region of the myogenin gene revealed that a responsive element to c-ski in myotubes is located at a distinct site upstream of the basal promoter\enhancer region.
mechanisms controlling the antagonism between cell growth and differentiation because growth cessation is a prerequisite for progression to muscle differentiation. The finding of four basic helix-loop-helix -class myogenic factors, called the MyoD family, has provided a clue to the molecular basis of acquisition of myogenic competency and muscle phenotype through subordinate muscle-specific gene activation [10] [11] [12] . Gene-targeting experiments on the myogenin gene resulted in a severe reduction in differentiated skeletal-muscle cells ; other myogenic factors failed to compensate for the disrupted myogenin gene, and functional redundancy was observed between MyoD and myf5 [13, 14] . Thus myogenin is an indispensable component of skeletal muscle differentiation. It would therefore appear to be impossible to understand the regulatory mechanisms of myogenic differentiation without clarifying how the expression of myogenic factors such as myogenin are regulated. Expression of muscle-specific genes in non-myogenic quail embryo cells has been induced by transfection of v-or c-ski [4] , and a muscle-specific enhancer has been reported to be activated by c-ski [15] . These results support the idea that c-ski is involved in transcriptional regulation of muscle differentiation.
To examine the physiological significance of the effect of c-ski on myogenesis, the present study focused on the following two points : (i) the effect of c-ski transfection on promoter\enhancer activity of the myogenin gene and a typical muscle gene, muscle creatine kinase (MCK), in cultures of a previously ' determined ' mouse muscle cell line, C2C12, and non-myogenic 10T1\2 cells ; (ii) identification of the part of the Ski protein responsible for the activity as a transcriptional factor. Here, we show that c-ski functions as a suppressor of promoter\enhancer activity of the myogenin gene in proliferating myoblasts and as a potentiator in postmitotic myotubes. Consistent with this finding, c-Ski undergoes a change in mobility on SDS\PAGE after myogenesis. Deletion analysis revealed the functional portions of the c-Ski protein required to potentiate transactivation of promoter\ enhancer activity in myotubes. In addition, deletion analysis of the upstream region of the myogenin gene suggests the presence of a distal c-ski-responsive element upstream of the basic promoter\enhancer region.
MATERIALS AND METHODS

Cell cultures
C2C12 mouse myoblast cells [16] were proliferated in Dulbecco's modified Eagle's medium (Gibco-BRL) supplemented with 10 % fetal bovine serum, 100 units\ml penicillin and 100 µg\ml streptomycin at 37 mC, 5 % CO # and 95 % humidity. The culture medium was exchanged every 48 h. In itro myogenesis was induced by replacement of the growth medium (10 % fetal bovine serum\Dulbecco's modified Eagle's medium) with differentiation medium, COSMEDIUM-001 (CosmoBio Co.) when the cell population reached confluence. Mouse C3H10T1\2 fibroblast cells were maintained in the same way and exposed to the same differentiation conditions at confluence which caused growth-arrest without myogenesis.
Constructions
For expression of c-ski and c-sno genes in C2C12 and 10T1\2 cells, two distinct mammalian expression vectors, pACT1 and pKCRH2PL, were used. The expression plasmids with β-actin promoter were constructed by subcloning full-length c-ski or csno cDNA [17] into pACT1 at the NcoI and XbaI sites and designated pActski and pActsno respectively. The pACT1 plasmid contains the 1n3 kb fragment of the 5h regulatory sequence of the chicken cytoplasmic β-actin gene [18] and simian virus 40 (SV40) polyadenylation signal. For construction of expression plasmids with SV40 early-gene promoter, the entire protein-coding sequence of the c-ski or c-sno cDNAs was excised from pActski or pActsno by digestion with NcoI and XbaI, and then recloned into the HindIII and XbaI sites located in the cloning sites of the pKCRH2PL plasmid and designated pKCRski and PKCRsno respectively. pKCRH2PL has the SV40 early-gene promoter, donor and acceptor splice sites derived from the rabbit α-globin gene, and polyadenylation sites originated from the rabbit α-globin gene and SV40 early gene [19] . Plasmids used to express a series of deleted c-ski mutants, Ski∆1 to Ski∆8, were generated as described previously [20, 21] by deleting the StuI-ApaLI fragment (∆1, nucleotides 209-853 ; nucleotide numbers are as in ref. [17] ), the ApaLI-EcoRI fragment (∆2, nucleotides 848-1543), the C-terminal fragment downstream of the EcoRI site (∆3, downstream of nucleotide 1548), the StuI-EcoRI fragment (∆4, nucleotides 209-1543), the ApaLI-MluI fragment (∆5, nucleotides 848-1854), the ApaLI-ScaI fragment (∆6, nucleotides 848-2059), a combination of ∆1 and ∆3 (∆7), and the MluI-ScaI fragment (∆8, nucleotides 1859-2059) respectively, and then filling up by Klenow polymerase followed by religation with Bgl III linker of appropriate length to adjust the reading frame.
A chloramphenicol acetyltransferase (CAT) reporter plasmid under the control of 3n7 kb upstream of mouse myogenin gene, pMYO3700CAT, was a gift from Dr. E. N. Olson [11] . The pMYO184CAT, pMYO1102CAT and pMYO1700CAT constructs were made by digestion of pMYO3700CAT with Pst1, Sst1 and HindIII respectively and religation.
A human MCK-CAT gene was a gift from Dr. J. J. Billadello [22] . It was made by insertion of 2620 nt of the human MCK 5h-flanking sequence including the transcription-start into the HindIII site of pSVOCAT in a 5h to 3h orientation upstream of the CAT gene. The resulting reporter plasmid was designated pMCKCAT2620.
Transfections and CAT assays
C2C12 and 10T1\2 cells were transfected by the calcium phosphate precipitation technique [23] . All plasmid DNAs used in our experiments were purified twice by CsCl centrifugation.
A 1n0 ml sample of calcium phosphate solution containing 25 µg of DNA was added to a 10 cm plate in which 4i10& cells were inoculated a day before transfection. The transfected DNAs were composed of 5 µg of effector plasmid (pACTski\snoN\snoA or pKCRski\snoN\snoA), 10 µg of CAT reporter plasmid, 2 µg of β-galactosidase expression vector (pKCRlacZ ) and 8 µg of salmon sperm DNA as carrier unless otherwise indicated. Cells were exposed to DNA for 15 h at 35 mC and 3 % CO # , recovered in the growth medium for 24 h after transfection at 37 mC and 5 % CO # and used to prepare the growing-cell extracts (G) for CAT assays. The transfected cells, which were recovered and cultured to near confluence, were differentiated for 48 h at 37 mC and 5 % CO # and then used to prepare the differentiated-cell extracts (D) for CAT assays.
CAT assays were carried out in a total volume of 120 µl using 0n125 µCi of [dichloroacetyl-1-"%C]chloramphenicol (Amersham) as described previously [24] . Cell extracts used for CAT assay were the supernatants prepared from C2C12 cells lysed in 0n25 M Tris\HCl, pH 7n8, by three cycles of freezing in liquid nitrogen and thawing at 37 mC and centrifuged at 10 000 g for 5 min. The radioisotopic scanner BAS2000 system (Fuji Film Co.) was employed to determine the ratio of acetylated to non-acetylated chloramphenicol after separation by TLC (silica-gel 60TLC ; Merck). Levels of CAT activity were normalized to β-galactosidase activity in the respective cell extracts.
Immunoprecipitation, immunobloting and immunofluorescence
To detect the expression level of Ski∆8 mutant, transfected C2C12 cells were lysed in 0n25 M Tris\HCl, pH 7n8, by three cycles of freezing in liquid nitrogen and thawing at 37 mC. After centrifugation at 10 000 g for 5 min, the supernatants were kept for assay of CAT and β-galactosidase activities and the pellets were extracted with buffer containing 1 % Nonidet P40, 0n1 % sodium deoxycholate, 400 mM NaCl, 1 % Traylol, 1 mM PMSF, 10 mM Na % P # O ( , 10 mM NaF, 4 mM EDTA, 2 mM Na $ VO % and 50 mM Tris\HCl, pH 7n5, for 30 min at 4 mC and then immunoprecipitated. For detection of mobility shift of c-Ski protein on SDS\PAGE, C2C12 cells were lysed with lysis buffer containing 10 mM Tris\HCl, pH 7n4, 10 mM NaCl, 3 mM MgCl # and 0n5 % Nonidet P40 supplemented with 1 mM PMSF and 1 % Trasylol for 15 min on ice, and then centrifuged at 2000 g for 5 min at 4 mC. The supernatants were re-centrifuged at 10 000 g for 30 min and the resultant supernatants were kept as the cytosolic fraction (C). The precipitates were washed twice with lysis buffer and the supernatant was kept as the washed supernatant (W). Washed precipitates were extracted with extraction buffer containing 1 % Nonidet P40, 0n1 % sodium deoxycholate, 400 mM NaCl, 10 mM Na % P # O ( , 10 mM NaF, 4 mM EDTA, 2 mM Na $ VO % and 50 mM Tris\HCl, pH 7n5, supplemented with 1 mM PMSF and 0n1 % Trasylol in a rotatory shaker for 30 min at 4 mC and centrifuged at 10 000 g for 30 min at 4 mC. The resultant supernatants were kept as the nuclear extracts (N). Nuclear extracts were diluted with 2 vol. of 20 mM Tris\HCl, pH 7n6, and centrifuged again at 10 000 g for 15 min. Diluted nuclear extracts, washed supernatant and cytosol fractions were precleared by incubation with Protein A-Sepharose beads (Pharmacia LKB Biotechnology) for 1 h at 4 mC, followed by centrifugation at 10 000 g for 5 min and then subjected to immunoprecipitation.
Immunoprecipitation was performed with rabbit polyclonal antibody against bacterially produced human c-Ski [21] for 2 h at 4 mC, followed by incubation with 20 µl of a 1 : 1 slurry of Protein A-Sepharose with excessive capacity for a further hour at 4 mC. The beads were washed with 50 mM Tris\HCl, pH 7n6, containing 0n5 % Nonidet P40, 10 µg\ml leupeptin, 1 % Trasylol and 1 mM PMSF, boiled in 40 µl of SDS sample buffer for 5 min and then resolved by SDS\PAGE [25] . The proteins were electrophoretically transferred to a nitrocellulose membrane sheet [26] and immunoblotted using mouse monoclonal antibody against human c-Ski protein produced in Escherichia coli, which recognizes an epitope on the N-terminal half (amino acids 46-260) of c-Ski protein. Anti-mouse IgG (Wako Chemical Co.) and mouse PAP (Zymed Laboratories) were used to detect the immunoreactive bands.
For immunofluorescence, C2C12 cells were grown at the growing phase on gelatin-coated coverslips, rinsed with PBS, fixed and permeabilized with a 1 : 1 mixture of methanol and acetone for 2 min. After being rinsed three times with PBS, the samples were blocked with 3 % BSA\PBS for 5 min at room temperature, and then subjected to immunofluorescent staining by incubation with rabbit anti-Ski antibody followed by Texas Red-conjugated anti-rabbit immunoglobulin (Amersham) and mounted with 10 % (w\v) glycerol in PBS.
RESULTS
Transcriptional regulation of myogenin promoter/enhancer activity by c-ski during C2C12 myogenesis
To test the effect of c-ski on trans-regulation of myogenin gene transcription, CAT-reporter gene activity of the 3n7 kb upstream region of the myogenin gene was determined when c-ski was overexpressed by co-transfection. The expression vector harbouring human c-ski cDNA (pKCRski) was co-transfected into myogenic C2C12 cells with the pMYO3700CAT reporter gene carrying the 3n7 kb upstream region of the myogenin gene containing its promoter and enhancer [11] . In the mock transfection, CAT activity was increased in postmitotic myotubes (mock in panel D) to more than ten times that in the growing phase (mock in panel G) ( Figure 1 ). As no myogenin gene transcript was detected in the proliferating C2C12 cells [6] , the transcription in the growing phase could be regarded as leaky or background activity in the artificial CAT assay and was defined as 1n0 (Table 1 ). In proliferating C2C12 cells, the leaky transcription was efficiently suppressed to approx. 20 % of the mock on c-ski overexpression. In contrast, myogenin promoter\ enhancer activity increased over 2n5-fold more that the ordinary enhancement in postmitotic myotubes on c-ski transfection (compare ' ski ' with ' mock ' in differentiated C2C12 cells in Table  1 ). These observations indicate that the c-ski gene product also functions as a transcriptional regulator, reversing the effect on the promoter\enhancer activity of the myogenin gene from suppression to potentiation upon myogenic differentiation ; this leads to overall enhancement of myogenin promoter\enhancer activity during myogenesis from no more than 12-fold in the mock transfection (compare ' mock ' in the differentiated state with ' mock ' in the growing state) to more than 150-fold when
Figure 1 pMYO3700CAT reporter activity was suppressed in proliferating but potentiated in differentiated C2C12 cells by co-transfection with c-ski
Myogenin promoter/enhancer-driven CAT reporter plasmids were transfected into C2C12 cells with expression vectors harbouring ski (pKCRski ), snoN (pKCRsnoN ), snoA (pKCRsnoA ), a combination of ski and sno or the mock plasmid (pKCRH2PL) as indicated. Panels G and D represent CAT activity in growing and differentiated C2C12 cells (at 48 h after induction of myogenesis) respectively.
Table 1 Qualification of pMYO3700CAT activity in differentiated C2C12 cells by co-transfection with c-ski
The conversion ratios to the acetylated form of chloramphenicol in Figure 1 were determined and normalized to β-galactosidase activity generated by co-transfection with pKCRlacZ. The results are meanspS.D. for four independent experiments.
CAT activity relative to control c-ski was transfected (compare ' ski ' in differentiated cells with ' ski ' in growing cells). Two types of sno cDNA (ski-related novel gene) of the ski gene family were subjected to CAT analysis with the same expression vector (pKCRsnoN and pKCRsnoA) to compare the transcriptional regulatory activity with that of c-ski (Figure 1 ). Overexpression of snoN or snoA resulted in weaker suppression in the growing phase but failed to potentiate the reporter activity of pMYO3700CAT in the differentiated cells (Table 1) . This is consistent with the fact that snoN is inferior to c-ski with respect to competence of both transforming and myogenesis-promoting activities [27] . SnoA protein lacks the C-terminal region from 
fibroblasts
Non-myogenic C3H10T1/2 fibroblasts were transfected with the same set of effector and reporter plasmids as shown in Figure 1 . The culture conditions for growing and growth-arrested 10T1/2 fibroblasts correspond to the stages of G and D in Figure 1 respectively. The results are means for three independent transfections.
CAT activity relative to control
amino acid 324 to the end (amino acid 728) of the c-Ski protein, suggesting that the C-terminus of c-Ski is important for the potentiation of myogenin gene transcription. On the other hand, members of the c-ski gene family share 54 % homology in the Nterminal region from amino acid 1 to 324 of c-Ski, and weak suppression in myoblasts is common for all three types of ski, snoN and snoA. Thus the N-terminus of the c-Ski protein may participate in the suppression observed in myoblasts. skidependent potentiation in postmitotic myotubes was not effected by co-expression of c-sno genes (' skijsnoN ' and ' skijsnoA ') despite a proposed interaction between c-Ski and c-SnoN [28] , suggesting that the interaction with the c-snoN gene product is not necessary for ski function in this case. Although the ski-dependent increase in myogenin promoter\enhancer activity in differentiated muscle cells is not inconsistent with the myogenesis-inducing activity of c-ski, we cannot rule out the possibility that such ski-dependent activation was induced simply by signals transmitted through cell-cell contacts or growth cessation rather than myogenesis. Therefore the same reporter assays were carried out using nonmyogenic 10T1\2 fibroblasts, which are not competent to undergo myogenesis in itro unless a member of the MyoD gene family is introduced. The differentiation conditions for C2C12 cells entrapped 10T1\2 cells in the growth-arrested state without expression of muscle-specific genes such as myogenin. As shown in Table 2 , effective suppression of CAT activity was observed in growing 10T1\2 cells on overexpression of c-ski, as was the case for growing C2C12 cells. However, even after 48 h of exposure to the same differentiation conditions as for the C2C12 cells, myogenin promoter\enhancer activity remained suppressed in ski-transfected 10T1\2 cells that were growth-arrested. These observations suggest that the ski-related potentiation of myogenin promoter\enhancer activity is specific for muscle differentiation and not induced by growth arrest.
The 5h-upstream regulatory region of the MCK gene does not respond to c-ski transfection
To examine whether c-Ski directly regulates expression of subordinate muscle-specific genes, CAT reporter assays were performed by transfection to C2C12 cells with pMCKCAT2620 plasmid carrying the 2n6 kb of cis-elements upstream of the human MCK gene instead of pMYO3700CAT. Unlike myogenin, MCK promoter\enhancer activity in all transfectants was not detectable in proliferating C2C12 cells unless cultured for 48 h under differentiation conditions (Table 3 ). In addition, there was no significant potentiation in the ski-and mocktransfected cells 48 h after differentiation, consistent with the results of Engert et al. [15] except that in our experiments no basal activity of MCK promoter\enhancer was detected in the myoblasts. These results mean that the region 2n6 kb upstream of the MCK gene is not susceptible to c-ski-dependent transactivation, i.e. c-ski is not able to activate MCK expression directly, unlike the myogenin gene.
A restricted C-terminal portion is essential for c-Ski activity as a transcriptional regulator
To determine the domains in the c-Ski protein required for up-regulation of myogenin promoter\enhancer activity in postmitotic myotubes, expression vectors harbouring various deletion mutants of human c-ski were co-transfected with the myogenin reporter gene, pMYO3700CAT, into C2C12 cells, and the resultant CAT reporter activities were examined ( Figure 2 ). First, we tested three mutants, ∆1, ∆2 and ∆3, to determine roughly which portion is essential for transcriptional control of the myogenin promoter. The three mutants lacked one-third of the N-terminus-proximal portion (∆1 ; amino acids 46-260), the central portion (∆2 ; amino acids 263-490) or the C-terminal portion (∆3 ; amino acids 493-728). Deletion of the N-and Cterminal portions independently resulted in a significant reduction in potentiation of CAT reporter activity. Both portions correspond to domains required for DNA binding of c-Ski in association with unidentified nuclear factors [21] and also for homodimer formation [28] . The combined deletions ∆1 and ∆3 (∆7) therefore resulted in an effective reduction in ski-dependent activation as compared with the combination ∆1 and ∆2 (∆4). However, further deletion of the central portion from the ∆1 mutant resulted in an unexpected recovery of activity (compare ∆1 with ∆4). Thus the central portion may have a negative effect on the transcriptional regulatory activity of the C-terminal portion, and the N-terminal portion is not essential for the activity of the C-terminal portion but appears to neutralize the negative effect of the central portion. The difference between ∆5 and ∆6 suggests that one of the parts essential for Ski function lies in a small region (amino acids 595-663). As expected, Ski∆8 lacking the corresponding C-terminal portion (amino acids 595-663) significantly reduced the potentiating activity.
It is necessary to preclude the possibility that the inability of the deletion mutants to activate the promoter\enhancer activity of the myogenin gene is due to less abundance of the protein than
Figure 2 Analysis of functional domains of Ski protein involved in the transactivation of myogenin promoter/enhancer
The histogram on the right shows relative values of pMYO3700CAT reporter activity in C2C12 cells after 48 h of differentiation when co-transfected with deletion mutants of c-Ski, constructs of which are shown on the left. Amino acid numbers are given on the constructs of Ski mutants. Expression vectors for a series of deletion mutants of c-Ski protein were constructed as described in the Materials and methods section. After transient transfections with 5 µg of skimutant expression plasmid and 10 µg of reporter plasmid, the transfected cells were recovered for 24 h and differentiated for 48 h, and then subjected to CAT reporter assay. CAT activities relative to those of the mock-plasmid (pACT1) transfection are indicated as meanspS.E.M. for four independent experiments.
Table 4 Effect of ∆8 mutant on pMYO3700CAT reporter activity when transfected with ten times more DNA than the wild-type
The Ski∆8 mutant construct was transfected to C2C12 cells with 20 µg of DNA, 10 times more than the wild-type pActski (2 µg). Relative CAT activities in cell extracts from transfected C2C12 cells after differentiation for 48 h were normalized to co-transfected β-galactosidase activity. The results are representative of duplicate independent experiments.
Transfection
Effector construct
Amount of transfected DNA ( µg)
CAT activity relative to control in differentiated C2C12 cells
in the wild-type. Since no appropriate antibody is available to detect all the deletion mutants, immunochemical analysis was focused on the inactive mutant with the most restricted deletion (∆8), the gene products of which are detectable with our antibodies. Unfortunately, the abundance of the products of the N-terminal deletion mutant ∆1 gene failed to be confirmed because of lack of reactivity with our anti-Ski antibodies. The detailed analysis on the ∆8 mutant (Table 4 and Figure 3) , however, confirmed the results on the mutants with more restricted deletions at the C-terminus, including the 595-663 sequence, independent of their expression levels, and also confirmed the significance of the C-terminus for potentiating the promoter\enhancer activity of the myogenin gene. When ∆8 was transfected with ten times more DNA than the wild-type, ∆8 protein appeared to accumulate in greater amounts than the wild-type ( Figure 3A , compare lane 1 with lane 2). Nonetheless, ∆8 still failed to potentiate CAT activity, suggesting that it is functionally deficient (Table 4) . Immunocytochemical analysis showed one positive c-Ski per four or five nuclei when c-ski was transfected transiently into C2C12 cells ( Figure 3B ), suggesting that endogenous c-Ski is not abundant enough to be visualized by immunofluorescence, and transfection efficiency is almost as low as 20 %. This efficiency is not uncommon for transient transfection experiments. Nuclear transport of ∆8 protein was also substantiated in the DNA-incorporated cell ( Figure 3B right panel, arrowhead). Therefore ∆8 had lost the ability to function as a transcriptional regulator of the myogenin gene in the nucleus, i.e. the functional domain resides on the portion deleted in the ∆8 mutant. Taken together the results indicate that the Cterminal (amino acids 595-663) portion containing a predicted α-helical structure is essential for the transcription-potentiating activity of the c-Ski protein in postmitotic myotubes and the Nterminal region may sustain the activity by blocking the inhibitory effect of the central portion.
Analysis of the c-ski-responsive element in the upstream region of the myogenin gene
The upstream region of the myogenin gene was deleted at nucleotides k1700, k1102 and k184 with appropriate restriction enzymes and religated to the CAT reporter gene to examine whether the c-ski-responsive element is located inside
Figure 4 Deletion analysis of myogenin 5h-flanking region responsible for Ski-dependent transcriptional activation
The 5h deleted pMYO3700CAT constructs were transfected with either pKCRH2PL (mock transfection ; solid bars) or pKCRski (ski transfection ; shaded bars) into C2C12 cells. After recovery for 24 h and differentiation for 48 h, cells were subjected to CAT reporter assay. The relative values are indicated as meanspS.E.M. for three or more independent transfections and shown as a histogram. The numbers in bp denote the distance relative to the transcriptionalstart site. The basal elements responsible for the muscle-specific expression of myogenin are depicted in the scheme of the pMYO184CAT construct.
or outside of the basic promoter\enhancer region. The c-skidependent potentiation of myogenin gene promoter\enhancer activity was sustained in the pMYO1102CAT construct but lost in the pMYO184CAT construct ( Figure 4 ). This result indicates the presence of a c-ski-responsive cis-element between nucleotides k1102 and k184 which is outside the basic promoter\enhancer region composed of E-boxes, MEF site and TATA box [11] . In addition, the loss of the c-ski-induced potentiation caused by deletion of the region from nucleotides k1102 to k184 appeared to be due to abolition of suppression in the mock transfection, suggesting that c-ski can mediate the release of suppression on myogenin gene transcription.
c-Ski protein undergoes alteration during in vitro myogenesis of C2C12 cells
Immunoblot analysis of the proteins immunoprecipitated with anti-Ski antibody showed a mobility shift of c-Ski protein to the upper band in the nucleus after in itro myogenesis of C2C12 cells ( Figure 5 ). This shift can be as much as 20 kDa, which would appear to be too large to be the phosphorylated form. This finding suggests that some unidentified modification or alternative splicing induces c-Ski to function as a myogenesisrelated transcription regulatory factor, although it is not known what kind of alteration to Ski occurs during muscle differentiation.
DISCUSSION
Using CAT reporter assays, we have demonstrated that the Ski protein is able to regulate the promoter\enhancer activity of the myogenin gene upstream region during in itro myogenesis. In addition, deletion mutants of c-ski revealed the regions responsible for potentiation of myogenin gene promoter\ enhancer activity. From these findings, possible transcription regulatory activity of c-Ski protein during terminal differentiation of skeletal muscle will be discussed.
Overexpression of c-ski showed ambivalent activity on transregulation of myogenin promoter\enhancer activity, i.e. suppression in the proliferating myoblast but potentiation in the differentiated myotube. In fibroblastic 10T1\2 cells, overexpression of c-ski caused persistant suppression of basal promoter\enhancer activity of the myogenin gene. These findings may reflect the fact that ski has the dual property of serving as a transcriptional suppressor and a muscle-specific potentiator according to the biological environment. In C2C12 cells, the transcriptional level of pMYO3700CAT was increased by approx. 12-fold during myogenesis in itro. As this value is rather low compared with the increase in the endogenous myogenin gene transcript [6] , CAT reporter activities using pMYO3700CAT may not completely represent transcription of the endogenous myogenin gene in C2C12. In this context, the transfected c-ski appears to reproduce the physiologically significant enhancement of myogenin gene transcription (more than 150-fold) by suppressing basal transcription in myoblasts and potentiating myogenesis-induced transcription in myotubes. Thus overexpression of c-ski is required to achieve full CAT reporter activity, suggesting that the endogenous c-Ski protein expressed in C2C12 cells is insufficient to activate the transfected pMYO3700CAT reporter gene fully.
As the c-ski transcript is invariably expressed [6] or increased twofold at most [29] during terminal differentiation of the skeletal-muscle cell line in itro, a post-translational modification of the c-Ski protein may underlie the conversion from suppression in myoblasts to potentiation in myotubes. In fact, an additional band of c-Ski protein with slower mobility was detected on SDS\PAGE after completion of in itro myogenesis, suggesting that c-Ski is regulated in a myogenesis-dependent manner to acquire the competence to potentiate myogenin gene transcription. Detailed analysis of the cause (e.g. post-translational modification or alternative splicing) of the mobility shift is underway.
The promoter\enhancer activity of the MCK gene was not potentiated by c-ski transfection as much as that of the myogenin gene in myotubes. c-ski-transfection failed to cause further enhancement of endogenous myogenin gene transcription (results not shown) probably because there is enough endogenous c-ski to cause full activation of the endogenous myogenin gene. Thus the failure of the c-ski gene to induce potentiation of MCK promoter\enhancer activity indicates that the c-ski-responsive element is not present in the upstream region of the MCK gene. The promoter\enhancer activities of MCK and myosin light chain (MLC) genes are activated by c-ski transfection in C2C12 myoblasts [15] , whereas c-ski transfection caused suppression in C2C12 myoblasts and potentiation in C2C12 myotubes of the promoter\enhancer activity of the myogenin gene in this study. The difference between the effects of c-ski transfection on the promoter\enhancer activities of the MLC\MCK genes and the myogenin gene may reflect the independent and distinctive functions of c-ski, suggesting that it functions as a multifunctional transcriptional regulator. To examine this, we generated a series of deletions in the myogenin 5h upstream region to determine the element responsible for the ski-dependent potentiation of myogenin gene transcription. A comparison of these deleted upstream regions introduced into CAT constructs for reporter analysis showed the locus responsible for the c-ski-dependent potentiation to be upstream of, and distinct from, the basal promoter\enhancer region of the myogenin gene. More detailed analysis suggests that known consensus sequences such as an E box are not sufficient to respond to c-ski (K. Ichikawa, T. Nagase, S. Ishii, A. Asano and N. Mimura, unpublished work), although an E box is reported to be a responsive element for c-ski overexpression in myoblasts with respect to MLC\MCK genes [15] .
Interaction with SnoN is not necessary for c-Ski to function as a transcriptional regulator in this case because co-transfection with snoN did not appear to increase the transcriptional activity of c-Ski. As c-Ski is unable to bind to DNA directly, some unidentified cofactor other than SnoN may be required for transcriptional activity of c-Ski. SnoN was also unable to increase myogenin gene transcription alone. SnoN shows 40 % homology with the locus (amino acids 595-663) responsible for the transcriptional regulatory activity of c-ski. A major difference in the region is the basic-amino-acid-rich stretch preceding the helical structure in Ski. SnoN is missing such basic amino acid cluster, suggesting that the positively charged amino acids in the locus are of importance.
The tandem repeats of 25 amino acids present in the Cterminal region (amino acids 515-695) probably assume an amphipathic α-helix and probably mediate homodimer formation by a coiled-coil interaction as predicted by Heyman and Stavnezer [28] . The region deleted in the ∆8 mutant corresponds to the Cterminal half of the tandem repeats. In addition, a 150-residue stretch within the N-terminal 250 amino acids was suggested to be a weaker self-binding domain for homodimer formation [28] and also required for c-ski to potentiate myogenesis-induced myogenin gene transcription in our study. Therefore homodimer formation may be responsible for the transcription-potentiating activity of the c-Ski protein. As c-Ski is not competent to bind DNA directly, the loss of trans-regulation by ∆8 may be due to its failure to interact with DNA-binding protein endowed with transcriptional activity (possibly muscle specific). Consistent with this idea, the locus deleted in ∆8 also corresponds to the region required to bind unidentified cofactors in the nucleus [21] . Taken together the results suggest that homodimer formation of c-Ski may be required for interaction with unidentified DNA- binding proteins and to mediate transcriptional regulation of the myogenin gene during in itro myogenesis. The biological significance of dimerization of the c-Ski protein has already been pointed out [28] . However, the molecular basis of the biological activity mediated by homodimer formation of c-Ski remains unknown. We demonstrated that both regions probably involved in homodimer formation are indispensable for c-ski to potentiate myogenesis-dependent transcription of the myogenin gene. This may suggest that the transcriptional regulation of the myogenin gene described here is one of the molecular bases for the biological function of homodimer formation in c-Ski proteins.
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